shutterstock_1532109092_sundry_photography

Sundry Photography / Shutterstock.com

4 January 2024Big PharmaMuireann Bolger

Abbott gets green light to challenge diabetes patents

Dispute hinges on clauses set out in decade-old settlement and licensing agreement | Federal Circuit unpersuaded by arguments suggesting that a federal court erred in denying a preliminary injunction.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

New York judge awards $33m to Abbott in diabetes test strip dispute

30 March 2023 H&H Wholesale Services found to have committed ‘fraud on the court’ | Final amount includes attorneys’ fees and costs.

Abbott sues former employee for alleged trade secrets theft

1 June 2023 Ex-scientist faces lawsuit for allegedly downloading thousands of files before leaving for a rival | Abbott seeks damages for ‘flagrant misconduct’ brought to its attention by successive employer.

More on this story

Abbott sues former employee for alleged trade secrets theft

1 June 2023 Ex-scientist faces lawsuit for allegedly downloading thousands of files before leaving for a rival | Abbott seeks damages for ‘flagrant misconduct’ brought to its attention by successive employer.

New York judge awards $33m to Abbott in diabetes test strip dispute

30 March 2023 H&H Wholesale Services found to have committed ‘fraud on the court’ | Final amount includes attorneys’ fees and costs.

More on this story

Abbott sues former employee for alleged trade secrets theft

1 June 2023 Ex-scientist faces lawsuit for allegedly downloading thousands of files before leaving for a rival | Abbott seeks damages for ‘flagrant misconduct’ brought to its attention by successive employer.

New York judge awards $33m to Abbott in diabetes test strip dispute

30 March 2023 H&H Wholesale Services found to have committed ‘fraud on the court’ | Final amount includes attorneys’ fees and costs.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent